ArticleMolecular cancer therapeutics2019

Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology.

Jia Xin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.